Search Results - "Oette, D H"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Treatment of Refractory Aplastic Anemia With Recombinant Human Granulocyte-Macrophage-Colony-Stimulating Factor by Champlin, R.E., Nimer, S.D., Ireland, P., Oette, D.H., Golde, D.W.

    Published in Blood (15-02-1989)
    “…Fifteen patients with refractory aplastic anemia or agranulocytosis received treatment with recombinant human granulocyte-macrophage-colony-stimulating factor…”
    Get full text
    Journal Article
  2. 2

    Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome by Groopman, J E, Mitsuyasu, R T, DeLeo, M J, Oette, D H, Golde, D W

    Published in The New England journal of medicine (03-09-1987)
    “…We administered recombinant (biosynthetic) human granulocyte-macrophage colony-stimulating factor (GM-CSF) to 16 patients with the acquired immunodeficiency…”
    Get more information
    Journal Article
  3. 3

    Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation by Brandt, S J, Peters, W P, Atwater, S K, Kurtzberg, J, Borowitz, M J, Jones, R B, Shpall, E J, Bast, Jr, R C, Gilbert, C J, Oette, D H

    Published in The New England journal of medicine (07-04-1988)
    “…Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) has been reported to increase the leukocyte count in subhuman primates subjected…”
    Get more information
    Journal Article
  4. 4

    Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy by Neidhart, J A, Mangalik, A, Stidley, C A, Tebich, S L, Sarmiento, L E, Pfile, J E, Oette, D H, Oldham, F B

    Published in Journal of clinical oncology (01-09-1992)
    “…This trial evaluated the optimum dosing regimen for recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) to support a dose-intensive…”
    Get more information
    Journal Article
  5. 5

    A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia by GUINAN, E. C, SIEFF, C. A, OETTE, D. H, NATHAN, D. G

    Published in Blood (15-09-1990)
    “…Nine pediatric patients (median age, 8 years; range, 0.7 to 19 years), eight with refractory aplastic anemia and one with newly diagnosed aplasia, were…”
    Get full text
    Journal Article
  6. 6

    Effects of Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor on Thrombopoiesis in Congenital Amegakaryocytic Thrombocytopenia by Guinan, Eva C., Lee, Yi Sheng, Lopez, Karen Dunn, Kohler, Susan, Oette, Dagmar H., Bruno, Edward, Kozakewich, Harry, Nathan, David G., Hoffman, Ronald

    Published in Blood (01-04-1993)
    “…Amegakaryocytic thrombocytopenia (AMT) is a rare and often fatal disorder of infancy and childhood presenting with isolated thrombocytopenia that progresses to…”
    Get full text
    Journal Article
  7. 7

    Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia by WRIGHT, D. G, KENNEY, R. F, OETTE, D. H, LARUSSA, V. F, BOXER, L. A, MALECH, H. L

    Published in Blood (15-08-1994)
    “…Recombinant human granulocyte colony-stimulating factor (G-CSF) treatment has been shown to increase average neutrophil counts substantially in patients with…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Contrasting effects of recombinant human granulocyte-macrophage colony- stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia by Wright, DG, Kenney, RF, Oette, DH, LaRussa, VF, Boxer, LA, Malech, HL

    Published in Blood (15-08-1994)
    “…Recombinant human granulocyte colony-stimulating factor (G-CSF) treatment has been shown to increase average neutrophil counts substantially in patients with…”
    Get full text
    Journal Article
  10. 10

    A phase I/II trial of recombinant granulocyte-macrophage colony- stimulating factor for children with aplastic anemia by Guinan, EC, Sieff, CA, Oette, DH, Nathan, DG

    Published in Blood (15-09-1990)
    “…Nine pediatric patients (median age, 8 years; range, 0.7 to 19 years), eight with refractory aplastic anemia and one with newly diagnosed aplasia, were…”
    Get full text
    Journal Article
  11. 11

    Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia by Guinan, EC, Lee, YS, Lopez, KD, Kohler, S, Oette, DH, Bruno, E, Kozakewich, H, Nathan, DG, Hoffman, R

    Published in Blood (01-04-1993)
    “…Amegakaryocytic thrombocytopenia (AMT) is a rare and often fatal disorder of infancy and childhood presenting with isolated thrombocytopenia that progresses to…”
    Get full text
    Journal Article
  12. 12

    Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor by Champlin, RE, Nimer, SD, Ireland, P, Oette, DH, Golde, DW

    Published in Blood (15-02-1989)
    “…Fifteen patients with refractory aplastic anemia or agranulocytosis received treatment with recombinant human granulocyte-macrophage-colony- stimulating factor…”
    Get full text
    Journal Article